ABT shares are ripping higher in recent action as the company achieves the vanguard in COVID-19 testing with its 5-minute results method -- which looks likely to set the new standard and redefine how we track this tragic disease.
This comes off a massively oversold low, and now we are back in the prior long-term range with supports in place.